title: Clinical effectiveness of sustained-release bupropion and behavior therapy for tobacco dependence in a clinical setting.
abstract: Despite decades of public education, cigarette smoking remains a serious health problem. The treatment approach at Tripler Army Medical Center is a unique collaboration of family practice physicians and health psychologists providing combination therapy to patients attempting to quit smoking. This article discusses a program evaluation of the Tripler Army Medical Center smoking cessation program. Patients attempting to quit smoking were assisted with a combination of cognitive-behavioral group therapy and sustained-release bupropion hydrochloride. At 6 months postintervention, patients who attended the smoking cessation programs were contacted via telephone and asked to complete a survey regarding their smoking status. One hundred forty-four participants completed the survey. Thirty-five percent of all contacted attendees remained abstinent from smoking at 6 months after intervention. A significantly greater percentage of men quit than women. There were no significant differences of abstinence rates by any other demographic characteristic or smoking history variable. Family practice physicians and health psychologists providing a combination of pharmacological and group cognitive-behavior therapy for nicotine dependence are effective in promoting abstinence from smoking.
authors.affiliation: Department of Psychology, Tripler Army Medical Center, Honolulu, HI 96859, USA. jay.earles@amedd.army.mil
authors.forename: Jay
authors.initials: J
authors.lastname: Earles
authors.forename: Raymond A
authors.initials: RA
authors.lastname: Folen
authors.forename: Mindy
authors.initials: M
authors.lastname: Ma
authors.forename: Michael
authors.initials: M
authors.lastname: Kellar
authors.forename: Renato
authors.initials: R
authors.lastname: Geralde
authors.forename: C orge
authors.initials: Co
authors.lastname: Dydek
mesh_terms: D000328:Adult; D016642:Bupropion / Q000008:administration & dosage*; D003692:Delayed-Action Preparations; D018765:Dopamine Uptake Inhibitors / Q000008:administration & dosage*; D005260:Female; D006254:Hawaii; D006293:Health Promotion; D006801:Humans; D008297:Male; D008889:Military Personnel; D012189:Retrospective Studies; D014029:Tobacco Use Disorder / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D003692:Delayed-Action Preparations; D018765:Dopamine Uptake Inhibitors; D016642:Bupropion